76 related articles for article (PubMed ID: 12836410)
1. [eIF2B and Cree Indian leukodystrophies].
Fogli A; Rodriguez D; Eymard-Pierre E; Boespflug-Tanguy O
Med Sci (Paris); 2003 Mar; 19(3):283-4. PubMed ID: 12836410
[No Abstract] [Full Text] [Related]
2. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in a child with Cree leukodystrophy.
Huntsman RJ; Seshia S; Lowry N; Lemire EG; Harder SL
J Child Neurol; 2007 Jun; 22(6):766-8. PubMed ID: 17641267
[TBL] [Abstract][Full Text] [Related]
4. The ovarioleukodystrophy.
Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
[TBL] [Abstract][Full Text] [Related]
5. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D
Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634
[No Abstract] [Full Text] [Related]
6. A case of ovarioleukodystrophy without eIF2B mutations.
Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
[TBL] [Abstract][Full Text] [Related]
7. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
[TBL] [Abstract][Full Text] [Related]
8. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
9. Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy.
Mascalchi M; De Grandis D; Ginestroni A; Pratesi A; Della Nave R; Scheper GC; van der Knaap MS
Neurology; 2006 Aug; 67(3):537-8. PubMed ID: 16894129
[No Abstract] [Full Text] [Related]
10. Hereditary leukodystrophies without identified mutations.
Robitaille Y
J Neurol Sci; 2005 Feb; 228(2):208-9. PubMed ID: 15694209
[No Abstract] [Full Text] [Related]
11. Vanishing white matter disease: the first reported chinese patient.
Wong SS; Luk DC; Wong VC; Scheper GC; van der Knaap MS
J Child Neurol; 2008 Jun; 23(6):710-4. PubMed ID: 18539998
[TBL] [Abstract][Full Text] [Related]
12. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
[TBL] [Abstract][Full Text] [Related]
13. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis.
Denier C; Orgibet A; Roffi F; Jouvent E; Buhl C; Niel F; Boespflug-Tanguy O; Said G; Ducreux D
Neurology; 2007 May; 68(18):1538-9. PubMed ID: 17470759
[No Abstract] [Full Text] [Related]
15. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
Pronk JC; Leegwater PA; van der Knaap MS
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
[TBL] [Abstract][Full Text] [Related]
16. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.
Matsui M; Mizutani K; Ohtake H; Miki Y; Ishizu K; Fukuyama H; Shimohata T; Onodera O; Nishizawa M; Takayama Y; Shibasaki H
Eur Neurol; 2007; 57(1):57-8. PubMed ID: 17119336
[No Abstract] [Full Text] [Related]
18. The spectrum of mutations for the diagnosis of vanishing white matter disease.
Scali O; Di Perri C; Federico A
Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
[TBL] [Abstract][Full Text] [Related]
19. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
Horzinski L; Gonthier C; Rodriguez D; Scherer C; Boespflug-Tanguy O; Fogli A
Ann Hum Genet; 2008 May; 72(Pt 3):410-5. PubMed ID: 18294360
[TBL] [Abstract][Full Text] [Related]
20. Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations.
Lee HN; Koh SH; Lee KY; Ki CS; Lee YJ
Eur J Neurol; 2009 Mar; 16(3):e42-3. PubMed ID: 19170749
[No Abstract] [Full Text] [Related]
[Next] [New Search]